Phil Young
InvestorSenior Advisor at US Venture Partners Β· Board director at HeartFlow Β· Board director at SentreHeart Β· Board director at ApniCure
Menlo Park, California, United States
Find your path to Phil
907 people in our graph share verified history with Phil β schools, employers, funds. One of them is your warm intro.
About
Phil Young is a Senior Advisor at USVP with over 40 years of experience in venture capital and executive leadership. He previously served as Managing General Partner at USVP for nearly 20 years and as CEO of an early-stage medical device company for eight years. Young has served on more than 30 boards of directors and chaired eCornell for nearly 20 years, during which time he helped grow the online learning platform to over $100 million in annual revenue serving more than 200,000 students worldwide.
ContactΒ· self-published, not guessed
Board director at HeartFlow
Intro paths
In turn, Phil can intro founders to HeartFlow's investors below.
HeartFlow's investors Β· 8
Co-founders at HeartFlow


Board director at SentreHeart
Intro paths
In turn, Phil can intro founders to SentreHeart's investors below.
Board director at ApniCure
Intro paths
In turn, Phil can intro founders to ApniCure's investors below.
ApniCure's investors Β· 1
Experience
- USVPSenior Advisorcurrent2010 β presentMenlo Park, CA
- Cornell UniversityTrusee Emerituscurrent2012 β presentTompkins County, New York, United States
- Cornell UniversityMember Board Of Trustees2004 β 2012Tompkins County, New York, United States
- Carlsmed, Inc.Directorcurrent2021 β presentCarlsbad, California, United States
- Palo Alto Medical FoundationTrustee2006 β 2025
- The Woodside Priory SchoolMember Board Of Trustees2015 β 2023Portola Valley, CA
- eCornellChair of the Board of Directors2002 β 2021Tompkins County, New York, United States
- Heartflow, IncDirector2010 β 2018Redwood City, CA
- ApniCureDirector2008 β 2017
- Aptus EndosystemsDirector2002 β 2015
- Dotomi, now a ValueClick CompanyDirector2002 β 2011Chicago, IL
- ZoranDirector1986 β 2011Santa Clara, CA
- RelayHealthDirector2000 β 2007
- Aerogen, Compugen, CardioVascular Imaging Systems, 3Dfx Interactive,PenedermDirector1990 β 2007
- St. Fancis MedicalDirector1999 β 2006
- SynarcDirector1995 β 2005San Francisco, CA
- CardioThoracic Surgery, FemRx, Vical, Xoma, La Jolla Pharma, Signal Pharma, Calyx TherapeuticsDirector1990 β 2005
- Oximetrix, Inc.President & CEO1977 β 1985Mountain View, CA
- New Court SecuritiesSenior Vice President1971 β 1977New York City
- McKinsey & CompanyAssociate1969 β 1971Washington, D.C.
- U.S. Atomic Energy CommissionNuclear Engineer, Fuel Element Manufacturing Process Development1963 β 1969Washington, D.C.
Skills & more
+5 more
Product ManagementExecutive ManagementFinancial ModelingStrategyManagementFrom Phil's professional profile.
Colleagues at US Venture Partners
Frequently asked questions
- Who is Phil Young?
- Phil Young is a Senior Advisor at USVP with over 40 years of experience in venture capital and executive leadership. He previously served as Managing General Partner at USVP for nearly 20 years and as CEO of an early-stage medical device company for eight years. Young has served on more than 30 boards of directors and chaired eCornell for nearly 20 years, during which time he helped grow the online learning platform to over $100 million in annual revenue serving more than 200,000 students worldwide.
- Where does Phil Young work?
- Phil Young is Senior Advisor at US Venture Partners and Board director at HeartFlow and Board director at SentreHeart and Board director at ApniCure.
- Where did Phil Young go to school?
- Phil Young studied at Harvard Business School (MBA); The George Washington University (Master of Science (M.S.), Applied Science/Engineering Physics); Cornell University (BME, Mechanical and Nuclear Engineering).
Same school
Also attended Harvard Business School2,000
+ 1,994 more
Also attended The George Washington University303
+ 297 more
Also attended Cornell University1,165
+ 1,159 more
Shared employers
Also worked at Cornell University186
+ 180 more













































